Literature DB >> 3213431

Mononuclear cell infiltrate and HLA-DR expression in low grade astrocytomas. An immunohistological study of 23 cases.

M L Rossi1, F Cruz-Sanchez, J T Hughes, M M Esiri, H B Coakham, T H Moss.   

Abstract

Frozen samples from 23 low grade (grade I and II) astrocytomas were studied by means of a panel of monoclonal antibodies to macrophages, lymphocytes (and their subsets) and HLA-DR antigens. Macrophages were present in low to moderate numbers in 38%-86% of cases, the variance in figures depending on the antibody used. T lymphocytes, the majority of CD8 phenotype, were detected in low numbers in 78% of tumours. B lymphocytes were scanty in 22% (5/22) and totally absent in the remaining cases. HLA-DR antigen was expressed by tumour cells in 35% (6/17) of cases. These findings indicate that in some low grade astrocytomas there is a mononuclear cell infiltrate with macrophages and secondarily CD8+ lymphocytes playing the major role. The significance of these findings remains speculative at present.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3213431     DOI: 10.1007/bf00687776

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  26 in total

1.  Immunohistologic evaluation of the lymphoreticular infiltrate of human central nervous system tumors.

Authors:  G W Wood; R A Morantz
Journal:  J Natl Cancer Inst       Date:  1979-03       Impact factor: 13.506

2.  Role of nominal antigen and Ia antigen in the binding of antigen-specific T lymphocytes to macrophages.

Authors:  O Werdelin; E M Shevach
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

3.  Immunocytochemical study of the cellular immune response in meningiomas.

Authors:  M L Rossi; F Cruz Sanchez; J T Hughes; M M Esiri; H B Coakham
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

4.  Immunohistological study of mononuclear cell infiltrate in malignant gliomas.

Authors:  M L Rossi; J T Hughes; M M Esiri; H B Coakham; D B Brownell
Journal:  Acta Neuropathol       Date:  1987       Impact factor: 17.088

5.  Lymphocytic infiltrates in primary glioblastomas and recidivous gliomas. Incidence, fate, and relevance to prognosis in 228 operated cases.

Authors:  L Palma; N Di Lorenzo; B Guidetti
Journal:  J Neurosurg       Date:  1978-12       Impact factor: 5.115

6.  Perivascular lymphocytic cuffing in astrocytomas.

Authors:  J Takeuchi; R O Barnard
Journal:  Acta Neuropathol       Date:  1976       Impact factor: 17.088

7.  On the presence of Ia-positive endothelial cells and astrocytes in multiple sclerosis lesions and its relevance to antigen presentation.

Authors:  U Traugott; L C Scheinberg; C S Raine
Journal:  J Neuroimmunol       Date:  1985-04       Impact factor: 3.478

8.  The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo.

Authors:  J J Mulé; S Shu; S A Rosenberg
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

9.  [Frequency and significance of lymphoplasmocyte infiltration in human gliomas (author's transl)].

Authors:  D Schiffer; G Croveri; C Pautasso
Journal:  Tumori       Date:  1974 May-Jun

10.  Lymphoreticular cells in human brain tumours and in normal brain.

Authors:  J P Phillips; O Eremin; J R Anderson
Journal:  Br J Cancer       Date:  1982-01       Impact factor: 7.640

View more
  9 in total

1.  The mononuclear cell infiltrate compared with survival in high-grade astrocytomas.

Authors:  M L Rossi; N R Jones; E Candy; J A Nicoll; J S Compton; J T Hughes; M M Esiri; T H Moss; F F Cruz-Sanchez; H B Coakham
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  Monocyte subpopulations in human gliomas: expression of Fc and complement receptors and correlation with tumor proliferation.

Authors:  T Morimura; C Neuchrist; K Kitz; H Budka; O Scheiner; D Kraft; H Lassmann
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

Review 3.  Combining cytotoxic and immune-mediated gene therapy to treat brain tumors.

Authors:  James F Curtin; Gwendalyn D King; Marianela Candolfi; Remy B Greeno; Kurt M Kroeger; Pedro R Lowenstein; Maria G Castro
Journal:  Curr Top Med Chem       Date:  2005       Impact factor: 3.295

4.  Detection of HLA-DR on microglia in the human brain is a function of both clinical and technical factors.

Authors:  L A Mattiace; P Davies; D W Dickson
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

5.  Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas.

Authors:  Shichuan Tan; Ryan Spear; Juan Zhao; Xiulian Sun; Pin Wang
Journal:  Front Genet       Date:  2022-06-27       Impact factor: 4.772

6.  An immunohistochemical study on HLA-DR expression in human meningiomas.

Authors:  N Ohara; K Hayashi; K Miyake; H J Jeon; K Takahashi; T Akagi
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

7.  Immune infiltrates and cytokines in gliomas.

Authors:  B Giometto; F Bozza; F Faresin; L Alessio; S Mingrino; B Tavolato
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

8.  The immune suppressive microenvironment of human gliomas depends on the accumulation of bone marrow-derived macrophages in the center of the lesion.

Authors:  Laura Pinton; Elena Masetto; Marina Vettore; Samantha Solito; Sara Magri; Marta D'Andolfi; Paola Del Bianco; Giovanna Lollo; Jean-Pierre Benoit; Hideho Okada; Aaron Diaz; Alessandro Della Puppa; Susanna Mandruzzato
Journal:  J Immunother Cancer       Date:  2019-02-27       Impact factor: 13.751

9.  Role of inflammation and oxidative stress mediators in gliomas.

Authors:  Alfredo Conti; Carlo Gulì; Domenico La Torre; Chiara Tomasello; Filippo F Angileri; M'hammed Aguennouz
Journal:  Cancers (Basel)       Date:  2010-04-26       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.